Summary
Structures and Sequence Alignment
The best structural homolog that predicted by 1. PB was
Q9BE57
(Smith-Magenis syndrome chromosomal region candidate gene 5 protein homolog) with a FATCAT P-Value: 0.00701 and RMSD of 3.09 angstrom. The sequence alignment identity is 86.8%.
Structural alignment shown in left. Query protein Q8TEV8 colored as red in alignment, homolog Q9BE57 colored as blue.
Query protein Q8TEV8 is also shown in right top, homolog Q9BE57 showed in right bottom. They are colored based on secondary structures.
Q8TEV8 MRRCLRVKTRRGQLGLASSCFEQHSCFSPRVNRILSAVQNTLCTGPSSQAPPQPPQASPPAAADHSRTPSLLASSHSASGGESLFQLYIASLAWPQNCCV 100 Q9BE57 MRRCLRVKTRRGQLGLASGCFEQHSCFSPRVNRILSAVQNTPCAGPSSQAPPQPPQASPPAAPDHSRTPSLLASSHSASGGESLFQLYMASLAWPQNCCV 100 Q8TEV8 LESCRRIPLGGLSSMENRRPLLRKGRLLRGQIHHSQTNEL------------ 140 Q9BE57 LESCRRIPLGGLSSMENRRPLLRKGRLLRGQIHHGQDNQLWGLTGAGALLSG 152
Go Annotations
1. PB indicates the go terms that are found by both PROST and BLAST.2. P indicates the go terms that are found by only PROST.
3. B indicates the go terms that are only annotated by BLAST.
Source | GO | Description |
---|---|---|
2. P | GO:0007266 | Rho protein signal transduction |
2. P | GO:0031267 | small GTPase binding |
2. P | GO:0030838 | positive regulation of actin filament polymerization |
2. P | GO:0012505 | endomembrane system |
2. P | GO:0031274 | positive regulation of pseudopodium assembly |
2. P | GO:0007254 | JNK cascade |
Homologs
1. PB indicates the homologs that are found by both PROST and BLAST.
2. P indicates homologs that are only found by PROST.
3. B indicates homologs that are only found by BLAST.
Source | Homolog | Description | FATCAT p-val | PROST Evalue | BLAST Evalue |
---|---|---|---|---|---|
1. PB | Q8TEV8 | Smith-Magenis syndrome chromosomal region candidate gene 5 protein | 0 | 5.69e-147 | 7.78e-98 |
1. PB | Q9BE57 | Smith-Magenis syndrome chromosomal region candidate gene 5 protein homolog | 7.01e-03 | 1.17e-46 | 1.34e-69 |
2. P | Q6XXX2 | Putative uncharacterized protein encoded by LINC00114 | 2.60e-01 | 1.22e-02 | NA |
2. P | Q8TGM9 | Putative uncharacterized protein YKR075W-A | 1.19e-01 | 1.09e-02 | NA |
2. P | P53087 | Putative uncharacterized protein YGL214W | 2.51e-01 | 1.61e-03 | NA |
2. P | Q2M3A8 | Putative uncharacterized protein MRGPRG-AS1 | 1.11e-01 | 2.43e-02 | NA |
2. P | Q8N9T2 | Putative uncharacterized protein CXorf42 | 2.85e-01 | 2.80e-05 | NA |
2. P | P59023 | Down syndrome critical region protein 10 | 5.81e-01 | 1.26e-04 | NA |
2. P | Q8N2B8 | Putative uncharacterized protein FLJ33534 | 4.38e-01 | 1.59e-04 | NA |
2. P | Q5TC04 | Putative uncharacterized protein ATP1A1-AS1 | 2.12e-01 | 7.70e-05 | NA |
2. P | Q9JMS2 | Uncharacterized protein YuaS | 2.97e-01 | 1.73e-02 | NA |
2. P | P16825 | Uncharacterized protein UL81 | NA | 3.74e-02 | NA |
2. P | O13913 | Uncharacterized protein C23C11.07 | 3.10e-01 | 7.33e-04 | NA |
2. P | Q54KS5 | Putative uncharacterized protein DDB_G0287145 | 3.80e-01 | 1.82e-02 | NA |
2. P | Q6ZTC4 | Putative uncharacterized protein FLJ44790 | 1.99e-01 | 2.68e-06 | NA |
2. P | Q8N9X3 | Putative uncharacterized protein encoded by LINC01356 | 4.38e-01 | 6.73e-04 | NA |
2. P | A0A023PXE5 | Putative uncharacterized protein YHL006W-A | 9.20e-01 | 2.88e-03 | NA |
2. P | Q6NZY7 | Cdc42 effector protein 5 | 1.54e-01 | 2.95e-02 | NA |
2. P | A0A023PYG5 | Putative uncharacterized protein YHL046W-A | 5.10e-01 | 3.09e-02 | NA |
2. P | O29555 | Uncharacterized protein AF_0703 | 4.95e-01 | 1.68e-04 | NA |
2. P | Q6ZR54 | Putative uncharacterized protein FLJ46641 | 1.19e-01 | 1.94e-03 | NA |
2. P | Q3E751 | Uncharacterized protein YPL119C-A | 4.65e-01 | 1.05e-03 | NA |
2. P | O13565 | Uncharacterized protein YLR358C | 6.25e-01 | 5.40e-03 | NA |
2. P | A0A1B0GUV1 | Uncharacterized protein C17orf114 | 1.33e-01 | 1.81e-07 | NA |
2. P | O13570 | Putative uncharacterized protein YPR142C | 7.50e-01 | 4.87e-02 | NA |